Recommend Limiting Dose and Duration of NSAIDs in High-CV-Risk Patients

Controversy will continue to brew over the safety of NSAIDs in patients at high cardiovascular risk.

Most NSAIDs have a warning about increased risk of CV events.

But the thinking has been that CV risk varies...with celecoxib (Celebrex, etc) being more risky and naproxen the least.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote